Abstract
Regulation of the turnover of monoamines in the central nervous system via monoamine receptors was first suggested by the finding that neuroleptic drugs increase the brain concentrations of dopamine (DA) metabolites such as 3-methoxytyramine (Carlsson and Lindqvist, 1963) and homovanillic acid (AndéN et al., 1964a). Successively, many different techniques have been used to show that the utilization and the synthesis of DA are accelerated following treatment with neuroleptic drugs. It has been generally accepted that the neuroleptic-induced stimulation of the DA turnover results from a compensatory activation of the DA neurons due to blockade of DA receptors. The receptors mediating these changes were originally supposed to be the classical postsynaptic receptors located on the effector cells. Later results have indicated, however, that other DA receptors might be involved in this regulation.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Åblad, B., Ek, L., Johansson, B., Waldeck, B.: Inhibitory effect of propranolol on the vasoconstrictor response to sympathetic nerve stimulation. J. Pharm. Pharmacol. 22, 627–628 (1970)
Adler-Graschinsky, E., Langer, S.Z.: Possible role of a β-adrenoceptor in the regulation of noradrenaline release by nerve stimulation through a positive feed-back mechanism. Br. J. Pharmacol. 53, 43–50 (1975)
Aghajanian, G.K.: Influence of drugs on the firing of serotonin-containing neurons in brain. Fed. Proc. 31, 91–96 (1972)
Aghajanian, G.K.: LSD and 2-bromo-LSD: comparison of effects on serotonergic neurones and on neurones in two serotonergic projection areas, the ventral lateral geniculate and amygdala. Neuropharmacol. 15, 521–528 (1976)
Aghajanian, G.K., Bunney, B.S.: Pharmacological characterization of dopamine “autoreceptors” by microiontophoretic single-cell recording studies. Adv. Biochem. Psychopharmacol. 16, 433–438 (1977 a)
Aghajanian, G.K., Bunney, B.S.: Dopamine “autoreceptors”: pharmacological characterization by microiontophoretic single cell recording studies. Naunyn-Schmiedebergs Arch. Pharmacol. 297, 1–7 (1977 b)
Aghajanian, G.K., Foote, W.E., Sheard, M.H.: Lysergic acid diethylamide: sensitive neuronal units in the midbrain raphe. Science 161, 706–708 (1968)
Aghajanian, G.K., Foote, W.E., Sheard, M.H.: Action of psychotogenic drugs on single midbrain raphe neurons. J. Pharmacol. Exp. Ther. 171, 178–187 (1970)
Aghajanian, G.K., Haigler, H.J., Bloom, F.E.: Lysergic acid diethylamide and serotonin: direct actions on serotonin-containing neurons in rat brain. Life Sci. 11 (I), 615–622 (1972)
Agid, Y., Javoy, F., Glowinski, J.: Chemical or electrolytic lesion of the substantia nigra: early effects on neostriatal dopamine metabolism. Brain Res. 74, 41–49 (1974)
Ahlenius, S., Engel, J.: Effects of small doses of haloperidol on timing behaviour. J. Pharm. Pharmacol. 23, 301–302 (1971)
Alousi, A., Weiner, N.: The regulation of norepinephrine synthesis in sympathetic nerves: effect of nerve stimulation, cocaine, and catecholamine-releasing agents. Proc. Nat. Acad. Sci. USA 56, 1491–1496 (1966)
Andén, N.-E.: Discussion of serotonin and dopamine in the extrapyramidal system. Adv. Pharmacol. 6A, 347–349 (1968)
Andén, N.-E.: Physiology and pharmacology of the nigro-neostriatal dopamine neurons. In: Progress in neuro-genetics. Barbeau, A., Brunette, J.-R. (eds.), pp. 265–271. Amsterdam: Excerpta Medica 1969
Andén, N.-E.: Effects of amphetamine and some other drugs on central catecholamine mechanisms. In: Amphetamines and related compounds. Costa, E., Garattini, S. (eds.), pp. 447–462. New York: Raven 1970
Andén, N.-E., Bédard, P.: Influences of cholinergic mechanisms on the function and turnover of brain dopamine. J. Pharm. Pharmacol. 23, 460–462 (1971)
Andén, N.-E., Fuxe, K.: A new dopamines-β-hydroxylase inhibitor: effects on the noradrenaline concentration and on the action of L-DOPA in the spinal cord. Br. J. Pharmacol. 43, 747–756 (1971)
Andén, N.-E., Grabowska, M.: Pharmacological evidence for a stimulation of dopamine neurons by noradrenaline neurons in the brain. Eur. J. Pharmacol. 39, 275–282 (1976)
Andén, N.-E., Grabowska, M.: FLA 136: selective agonist at central alpha-adrenoreceptors mediating changes in the turnover of noradrenaline. Naunyn-Schmiedebergs Arch. Pharmacol. 298, 239–243 (1977)
Andén, N.-E., Stock, G.: Effect of clozapine on the turnover of dopamine in the corpus striatum and in the limbic system. J. Pharm. Pharmacol. 25, 346–348 (1973)
Andén, N.-E., Strömbom, U.: Adrenergic receptor blocking agents: effects on central noradrenaline and dopamine receptors and on motor activity. Psychopharmacologia 38, 91–103 (1974)
Andén, N.-E., Strömbom, U.: Stimulation of central adrenergic alpha-receptors by L-dopa, α- methyldopa and clonidine. In: Central action of drugs in blood pressure regulation. Davies, D.S., Reid, J.L. (eds.), pp. 225–236. Tunbridge Wells: Pitman 1975
Andén, N.-E., Roos, B.-E., Werdinius, B.: Effects of chlorpromazine, haloperidol and reserpine on the levels of phenolic acids in rabbit corpus striatum. Life Sci. 3, 149–158 (1964 a)
Andén, N.-E., Häggendal, J., Magnusson, T., Rosengren, E.: The time course of the disappear-ance of noradrenaline and 5-hydroxytryptamine in the spinal cord after transection. Acta Physiol. Scand. 62, 115–118 (1964 b)
Andén, N.-E., Jukes, M.G.M., Lundberg, A.: Spinal reflexes and monoamine liberation. Nature 202, 1222–1223 (1964c)
Andén, N.-E., Carlsson, A., Hillarp, N.-Å., Magnusson, T.: 5-Hydroxytryptamine release by nerve stimulation of the spinal cord. Life Sci. 3, 473–478 (1964d)
Andén, N.-E., Magnusson, T., Roos, B.-E., Werdinius, B.: 5-Hydroxyindoleacetic acid of rabbit spinal cord normally and after transection. Acta Physiol. Scand. 64, 193–196 (1965)
Andén, N.-E., Dahlstrom, A., Fuxe, K., Larsson, K., Olson, L., Ungerstedt, U.: Ascending monoamine neurons to the telencephalon and diencephalon. Acta Physiol. Scand. 67, 313–326 (1966 a)
Andén, N.-E., Jukes, M.G.M., Lundberg, A., Vyklický, L.: The effect of DOPA on the spinal cord. 1. Influence on transmission from primary afferents. Acta Physiol. Scand. 67,373–386 (1966 b)
Andén, N.-E., Jukes, M.G.M., Lundberg, A.: The effect of DOPA on the spinal cord. 2. A pharmacological analysis. Acta Physiol. Scand. 67, 387–397 (1966 c)
Andén, N.-E., Dahlström, A., Fuxe, K., Larsson, K.: Functional role of the nigro-neostriatal dopamine neurons. Acta Pharmacol. (Kbh.) 24, 263–274 (1966d)
Andén, N.-E., Corrodi, H., Dahlström, A., Fuxe, K., Hókfelt, T.: Effects of tyrosine hydroxylase inhibition on the amine levels of central monoamine neurons. Life Sci. 5, 561–568 (1966e)
Andén, N.-E., Fuxe, K., Hökfelt, T.: The importance of the nervous impulse flow for the de-pletion of the monoamines from central neurones by some drugs. J. Pharm. Pharmacol. 18, 630–632 (19660
Andén, N.-E., Corrodi, H., Fuxe, K., Hökfelt, T.: Increased impulse flow in bulbospinal noradrenaline neurons produced by catecholamine receptor blocking agents. Eur. J. Pharmacol. 2, 59–64 (1967 a)
Andén, N.-E., Rubenson, A., Fuxe, K., Hökfelt, T.: Evidence for dopamine receptor stimulation by apomorphine. J. Pharm. Pharmacol. 19, 627–629 (1967 b)
Andén, N.-E., Corrodi, H., Fuxe, K., Hókfelt, T.: Evidence for a central 5-hydroxytryptamine receptor stimulation by lysergic acid diethylamide. Br. J. Pharmacol. 34, 1–7 (1968 a)
Andén, N.-E., Börjesson, B., Magnusson, T.: Normetanephrine accumulation in the spinal cord due to nerve impulse activity. Eur. J. Pharmacol. 4, 349–351 (1968 b)
Andén, N.-E., Corrodi, H., Fuxe, K., Hökfelt, B., Hokfelt, T., Rydin, C., Svensson, T.: Evidence for a central noradrenaline receptor stimulation by clonidine. Life Sci. 9 (I), 513–523 (1970 a)
Andén, N.-E., Butcher, S.G., Corrodi, H., Fuxe, K., Ungerstedt, U.: Receptor activity and turnover of dopamine and noradrenaline after neuroleptics. Eur. J. Pharmacol. 11, 303–314 (1970b)
Andén, N.-E., Corrodi, H., Fuxe, K.: Hallucinogenic drugs of the indolealkylamine type and central monoamine neurons. J. Pharmacol. Exp. Ther. 179, 236–249 (1971a)
Andén, N.-E., Corrodi, H., Fuxe, K., Ungerstedt, U.: Importance of nervous impulse flow for the neuroleptic induced increase in amine turnover in central dopamine neurons. Eur. J. Pharmacol. 75, 193–199 (1971b)
Andén, N.-E., Engel, J., Rubenson, A.: Mode of action of L-DOPA on central noradrenaline mechanisms. Naunyn-Schmiedebergs Arch. Pharmacol. 273, 1–10 (1972a)
Andén, N.-E., Bédard, P., Fuxe, K., Ungerstedt, U.: Early and selective increase in brain dopamine levels after axotomy. Experientia 28, 300–301 (1972 b)
Andén, N.-E., Corrodi, H., Fuxe, K.: Effect of neuroleptic drugs on central catecholamine turnover assessed using tyrosine- and dopamines-β-hydroxylase inhibitors. J. Pharm. Pharmacol. 24, 177–182 (1972c)
Andén, N.-E., Strombom, U., Svensson, T.H.: Dopamine and noradrenaline receptor stimulation: reversal of reserpine-induced suppression of motor activity. Psychopharmacologia 29, 289–298 (1973)
Andén, N.-E., Corrodi, H., Fuxe, K., Meek, J.L.: Hallucinogenic phenylethylamines: interactions with serotonin turnover and receptors. Eur. J. Pharmacol. 25, 176–184 (1974a)
Andén, N.-E., Magnusson, T., Stock, G.: Effect of anaesthetic agents on the synthesis and dis-appearance of brain dopamine normally and after haloperidol, KC1 or axotomy. Naunyn- Schmiedebergs Arch. Pharmacol. 283, 409–418 (1974b)
Andén, N.-E., Grabowska, M., Strombom, U.: Different alpha-adrenoreceptors in the central nervous system mediating biochemical and functional effects of clonidine and receptor blocking agents. Naunyn-Schmiedebergs Arch. Pharmacol. 292, 43–52 (1976)
Anderson, E.G., Shibuya, T.: The effects of 5-hydroxytryptophan and l-tryptophan on spinal synaptic activity. J. Pharmacol. Exp. Ther. 153, 352–360 (1966)
Asper, H., Baggiolini, M., Burki, H.R., Lauener, H., Ruch, W., Stille, G.: Tolerance phenomena with neuroleptics. Catalepsy, apomorphine stereotypies and striatal dopamine metabolism in the rat after single and repeated administration of loxapine and haloperidol. Eur. J. Pharmacol. 22, 287–294 (1973)
Axelrod, J.: Noradrenaline: fate and control of its biosynthesis. Science 173, 598–606 (1971)
Bartholini, G.: Differential effect of neuroleptic drugs on dopamine turnover in extrapyramidal and limbic system. J. Pharm. Pharmacol. 28, 429–433 (1976)
Bartholini, G., Stadler, H., Gadea Ciria, M., Lloyd, K.G.: The use of the push-pull cannula to estimate the dynamics of acetylcholine and catecholamines within various brain areas. Neuropharmacol. 15, 515–519 (1976)
Bédard, P., Larochelle, L.: Effect of section of the strionigral fibers on dopamine turnover in the forebrain of the rat. Exp. Neurol. 41, 314–322 (1973)
Bédard, P., Carlsson, A., Lindqvist, M.: Effect of a transverse cerebral hemisection on 5-hydroxytryptamine metabolism in the rat brain. Naunyn-Schmiedebergs Arch. Pharmacol 272, 1–15 (1972)
Bell, L.J., Iversen, L.L., Uretsky, N.J.: Time course of the effects of 6-hydroxydopamine on catecholamine-containing neurones in rat hypothalamus and striatum. Br. J. Pharmacol. 40, 790–799 (1970)
Bergström, S., Farnebo, L.-O., Fuxe, K.: Effect of prostaglandin E2 on central and peripheral catecholamine neurons. Eur. J. Pharmacol. 21, 362–368 (1973)
Bernheimer, H., Hornykiewicz, O.: Wirkung von Phenothiazinderivaten auf den Dopamin- (=3-Hydroxytyramin-) Stoffwechsel im Nucleus caudatus. Naunyn-Schmiedebergs Arch. Exp. Pathol. Pharmakol. 251, 135 (1965)
Bertler, Å., Rosengren, E.: Occurrence and distribution of dopamine in brain and other tissues. Experientia 15, 10–11 (1959)
Bowers, Jr., M.B., Rozitis, A.: Regional differences in homovanillic acid concentrations after acute and chronic administration of antipsychotic drugs. J. Pharm. Pharmacol. 26, 743–745 (1974)
Braestrup, C., Nielsen, M.: Regulation in the central norepinephrine neurotransmission induced in vivo by alpha adrenoceptor active drugs. J. Pharmacol. Exp. Ther. 198, 596–608 (1976)
Brodie, B.B., Costa, E., Dlabac, A., Neff, N.H., Smookler, H.H.: Application of steady state kinetics to the estimation of synthesis rate and turnover time of tissue catecholamines. J. Pharmacol. Exp. Ther. 154, 493–498 (1966)
Brown, G.L., Gillespie, J.S.: The output of sympathetic transmitter from the spleen of the cat. J. Physiol. (Lond.) 138, 81–102 (1957)
Bryant, B.J., McCulloch, M.W., Rand, M.J., Story, D.F.: Release of 3H-(–)-noradrenaline from guinea-pig hypothalamic slices: effects of adrenoceptor agonists and antagonists. Br. J. Pharmacol. 53, 454 P (1975)
Bunney, B.S., Aghajanian, G.K.: d-Amphetamine-induced inhibition of central dopaminergic neurons: mediation by a striato-nigral feedback pathway. Science 192, 391–393 (1976)
Bunney, B.S., Aghajanian, G.K., Roth, R.H.: Comparison of effects of L-DOPA, amphetamine and apomorphine on firing rate of rat dopaminergic neurones. Nature New Biol. 245, 123–125 (1973 a)
Bunney, B.S., Walters, J.R., Roth, R.H., Aghajanian, G.K.: Dopaminergic neurons: effect of antipsychotic drugs and amphetamine on single cell activity. J. Pharmacol. Exp. Ther. 185, 560–571 (1973 b)
Bunney, B.S., Walters, J.R., Kuhar, M.J., Roth, R.H., Aghajanian, G.K.: DampL amphetamine stereoisomers: comparative potencies in affecting the firing of central dopaminergic and noradrenergic neurons. Psychopharmacol. Commun. 1, 177–190 (1975)
Carlsson, A.: Receptor-mediated control of dopamine metabolism. In: Pre- and postsynaptic receptors. Usdin, E., Bunney, Jr., W.E. (eds.), pp. 49 - 63. New York: Marcel Dekker 1975
Carlsson, A.: Mechanism of action of neuroleptic drugs. In: Psychopharmacology: a generation of progress. Lipton, M.A., DiMascio, A., Killam, K.F. (eds.), pp. 1057–1070. New York: Raven 1978
Carlsson, A., Lindqvist, M.: Effect of chlorpromazine or haloperidol on formation of 3- methoxytyramine and normetanephrine in mouse brain. Acta Pharmacol. (Kbh.) 20, 140–144 (1963)
Carlsson, A., Lindqvist, M.: The effect of L-tryptophan and some psychotropic drugs on the formation of 5-hydroxytryptophan in the mouse brain in vivo. J. Neural Transm. 33, 23–43 (1972)
Carlsson, A., Falck, B., Hillarp, N.-Å.: Cellular localization of brain monoamines. Acta Physiol. Scand. 56 [Suppl. 196], 1–28 (1962)
Carlsson, A., Magnusson, T., Rosengren, E.: 5-Hydroxytryptamine of the spinal cord normally and after transection. Experientia 19, 359–360 (1963 a)
Carlsson, A., Corrodi, H., Waldeck, B.: α-Substituierte Dopacetamide als Hemmer der Catechol-O-methyl-transferase und der enzymatischen Hydroxylierung aromatischer Aminosäuren. In den Catecholamin-Metabolismus eingreifende Substanzen 2. Helv. Chim. Acta 66, 2271–2285 (1963 b)
Carlsson, A., Davis, J.N., Kehr, W., Lindqvist, M., Atack, C.V.: Simultaneous measurement of tyrosine and tryptophan hydroxylase activities in brain in vivo using an inhibitor of the aromatic amino acid decarboxylase. Naunyn-Schmiedebergs Arch. Pharmacol. 275, 153–168 (1972)
Carlsson, A., Lindqvist, M., Magnusson, T., Atack, C.: Effect of acute transection on the syn-thesis and turnover of 5-HT in the rat spinal cord. Naunyn-Schmiedebergs Arch. Pharmacol. 277, 1–12 (1973)
Carlsson, A., Kehr, W., Lindqvist, M.: The role of intraneuronal amine levels in the feedback control of dopamine, noradrenaline and 5-hydroxytryptamine synthesis in rat brain. J. Neural Transm. 39, 1–19 (1976)
Carlsson, A., Kehr, W., Lindqvist, M.: Agonist-antagonist interaction on dopamine receptors in brain, as reflected in the rates of tyrosine and tryptophan hydroxylation. J. Neural Transm. 40, 99–113 (1977)
Cedarbaum, J.M., Aghajanian, G.K.: Noradrenergic neurons of the locus coeruleus: inhibition by epinephrine and activation by the α-antagonist piperoxane. Brain Res. 112, 413–419 (1976)
Chase, T.N., Katz, R.I., Kopin, I.J.: Release of [3H]serotonin from brain slices. J. Neurochem. 16, 607–615 (1969)
Christiansen, J., Squires, R.F.: Antagonistic effects of apomorphine and haloperidol on rat striatal synaptosomal tyrosine hydroxylase. J. Pharm. Pharmacol. 26, 367–369 (1974)
Corrodi, H., Hanson, L.C.F.: Central effects of an inhibitor of tyrosine hydroxylation. Psychopharmacologia 10, 116–125 (1966)
Corrodi, H., Fuxe, K., Hokfelt, T.: The effect of some psychoactive drugs on central monoamine neurons. Eur. J. Pharmacol. 1, 363–368 (1967)
Dahlström, A., Fuxe, K.: Evidence for the existence of monoamine-containing neurons in the central nervous system. I. Demonstration of monoamines in the cell bodies of brain stem neurons. Acta Physiol. Scand. 62 [Suppl. 232], 1–55 (1964)
Dahlström, A. Fuxe, K.: Evidence for the existence of monoamine neurons in the central nervous system. II. Experimentally induced changes in the intraneuronal amine levels of bulbospinal neuron systems. Acta Physiol. Scand. 64 [Suppl. 247], 1–36 (1965)
Dahlström, A., Fuxe, K., Kernell, D., Sedvall, G.: Reduction of the monoamine stores in the terminals of bulbospinal neurones following stimulation in the medulla oblongata. Life Sci. 4, 1207–1212 (1965)
Dairman, W., Gordon, R., Spector, S., Sjoerdsma, A., Udenfriend, S.: Increased synthesis of catecholamines in the intact rat following administration of a-adrenergic blocking agents. Mol. Pharmacol. 4, 457–464 (1968)
Da Prada, M., Pletscher, A.: On the mechanism of chlorpromazine-induced changes of cerebral homovanillic acid levels. J. Pharm. Pharmacol. 18, 628–630 (1966)
De Groat, W.C., Voile, R.L.: The actions of the catecholamines on transmission in the superior cervical ganglion of the cat. J. Pharmacol. Exp. Ther. 154, 1–13 (1966)
Di Chiara, G., Porceddu, M.L., Fratta, W., Gessa, G.L.: Postsynaptic receptors are not essential for dopaminergic feedback regulation. Nature 267, 270–272 (1977)
Dubocovich, M., Langer, S.Z.: Negative feed-back regulation of noradrenaline release by nerve stimulation in the perfused cat’s spleen: differences in potency of phenoxybenzamine in blocking the pre- and post-synaptic adrenergic receptors. J. Physiol. (Lond.) 237, 505–519 (1974)
Ebstein, B., Roberge, C., Tabachnick, J., Goldstein, M.: The effect of dopamine and of apomorphine on dB-cAMP-induced stimulation of synaptosomal tyrosine hydroxylase. J. Pharm. Pharmacol. 26, 975–977 (1974)
Eccles, R.M., Libet, B.: Origin and blockade of the synaptic responses of curarized sympathetic ganglia. J. Physiol. (Lond.) 157, 484–503 (1961)
Emmelin, N.: Action of transmitters on the responsiveness of effector cells. Experientia 21, 57–65 (1965)
Enero, M.A., Langer, S.Z., Rothlin, R.P., Stefano, F.J.E.: Role of the α-adrenoceptor in regulating noradrenaline overflow by nerve stimulation. Br. J. Pharmacol. 44, 672–688 (1972)
Ernst, A.M.: Relation between the action of dopamine and apomorphine and their O-methylated derivatives upon the CNS. Psychopharmacologia 7, 391–399 (1965)
Ernst, A.M.: Mode of action of apomorphine and dexamphetamine on gnawing compulsion in rats. Psychopharmacologia 10, 316–323 (1967)
Ernst, A.M.: The role of biogenic amines in the extra-pyramidal system. Acta Physiol. Pharmacol. Neerl. 15, 141–154 (1969)
Ernst, A.M., Smelik, P.G.: Site of action of dopamine and apomorphine on compulsive gnawing behaviour in rats. Experientia 22, 837–838 (1966)
Farnebo, L.-O., Hamberger, B.: Drug-induced changes in the release of [3H]-noradrenaline from field stimulated rat iris. Br. J. Pharmacol. 43, 97–106 (1971a)
Farnebo, L.-O., Hamberger, B.: Drug-induced changes in the release of 3H-monoamines from field stimulated rat brain slices. Acta Physiol. Scand., [Suppl. 371], 35–44 (1971b)
Faull, R.L. M., Laverty, R.: Changes in dopamine levels in the corpus striatum following lesions in the substantia nigra. Exp. Neurol. 23, 332–340 (1969)
Fog, R.L., Randrup, A., Pakkenberg, H.: Aminergic mechanisms in corpus striatum and amphetamine-induced stereotyped behaviour. Psychopharmacologia 11, 179–183 (1967)
Fog, R., Randrup, A., Pakkenberg, H.: Lesions in corpus striatum and cortex of rat brains and the effect on pharmacologically induced stereotyped, aggressive and cataleptic behaviour. Psychopharmacologia 18, 346–356 (1970)
Freedman, D.X., Gottlieb, R., Lovell, R.A.: Psychotomimetic drugs and brain 5-hydroxytryptamine metabolism. Biochem. Pharmacol. 19, 1181–1188 (1970)
Fuxe, K.: Evidence for the existence of monoamine neurons in the central nervous system. IV. Distribution of monoamine nerve terminals in the central nervous system. Acta Physiol. Scand. 64 [Suppl. 247], 37–85 (1965)
Fuxe, K., Holmstedt, B., Jonsson, G.: Effects of 5-methoxy-N,N-dimethyltryptamine on central monoamine neurons. Eur. J. Pharmacol. 19, 25–34 (1972)
Gallager, D.W., Aghajanian, G.K.: Inhibition of firing of raphe neurones by tryptophan and 5-hydroxytryptophan: blockade by inhibiting serotonin synthesis with Ro-4-4602. Neuropharmacology 15, 149–156 (1976)
Garcia-Munoz, M., Nicolaou, N.M., Tulloch, I.F., Wright, A.K., Arbuthnott, G.W.: Feedback loop or output pathway in striato-nigral fibres? Nature 265, 363–365 (1977)
Geffen, L.B., Jessell, T.M., Cuello, A.C., Iversen, L.L.: Release of dopamine from dendrites in rat substantia nigra. Nature 260, 258–260 (1976)
Gessa, G.L., Vargiu, L., Crabai, F., Boero, G.C., Caboni, F., Camba, R.: Selective increase of brain dopamine induced by gamma-hydroxybutyrate. Life Sci. 5, 1921–1930 (1966)
Gey, K.F., Pletscher, A.: Acceleration of turnover of 14C-catecholamines in rat brain by chlorpromazine. Experientia 24, 335–336 (1968)
Gordon, R., Reid, J.V.O., Sjoerdsma, A., Udenfriend, S.: Increased synthesis of norepinephrine in the rat heart on electrical stimulation of the stellate ganglia. Mol. Pharmacol. 2, 610–613 (1966)
Grabowska, M.: Influence of apomorphine on brain serotonin turnover rate. Pharmacol. Biochem. Behav. 3, 589–591 (1975)
Grabowska, M., Andén, N.-E.: Noradrenaline synthesis and utilization: control by nerve impulse flow under normal conditions and after treatment with alpha-adrenoreceptor blocking agents. Naunyn-Schmiedebergs Arch. Pharmacol. 232, 53–58 (1976)
Graham, A.W., Aghajanian, G.K.: Effects of amphetamine on single cell activity in a catecholamine nucleus, the locus coeruleus. Nature 234, 100–102 (1971)
Grahame-Smith, D.G.: Studies in vivo on the relationship between brain tryptophan, brain 5- HT synthesis and hyperactivity in rats treated with a monoamine oxidase inhibitor and L- tryptophan. J. Neurochem. 18, 1053–1066 (1971)
Groves, P.M., Wilson, C.J., Young, S.J., Rebec, G.V.: Self-inhibition by dopaminergic neurons. Science 190, 522–529 (1975)
Guldberg, H.C., Yates, C.M.: Effects of chlorpromazine on the metabolism of catecholamines in dog brain. Br. J. Pharmacol. 36, 535–548 (1969)
Häggendal, J.: Some further aspects on the release of the adrenergic transmitter. In: New aspects of storage and release mechanisms of catecholamines. Bayer-Symposium II. Schümann, H.J., Kroneberg, G. (eds.), pp. 100–109. Berlin, Heidelberg, New York: Springer 1970
Häggendal, J., Johansson, B., Jonason, J., Ljung, B.: Effects of phenoxybenzamine on transmitter release and effector response in the isolated portal vein. J. Pharm. Pharmacol. 24, 161–164 (1972)
Haigier, H.J., Aghajanian, G.K.: Mescaline and LSD: direct and indirect effects on serotonin- containing neurons in brain. Eur. J. Pharmacol. 21, 53–60 (1973)
Haigier, H.J., Aghajanian, G.K.: Lysergic acid diethylamide and serotonin: a comparison of effects on serotonergic neurons and neurons receiving a serotonergic input. J. Pharmacol. Exp. Ther. 188, 688–699 (1974a)
Haigier, H.J., Aghajanian, G.K.: Peripheral serotonin antagonists: failure to antagonize serotonin in brain areas receiving a prominent serotonergic input. J. Neural Transm. 35, 257–273 (1974 b)
Hanson, L.C.F.: Evidence that the central action of (+)-amphetamine is mediated via catechol-amines. Psychopharmacologia 10, 289–297 (1967)
Hedqvist, P.: Studies on the effect of prostaglandins E1 and E2 on the sympathetic neuromuscular transmission in some animal tissues. Acta Physiol. Scand. [Suppl. 345], 1–40 (1970)
Hedqvist, P.: Dissociation of prostaglandin and α-receptor mediated control of adrenergic transmitter release. Acta Physiol. Scand. 87, 42A–43 A (1973)
Hoefke, W., Kobinger, W.: Pharmakologische Wirkungen des 2-(2,6-Dichlorphenylamino)-2- imidazolin-hydrochlorids, einer neuen antihypertensiven Substanz. Arzneimittel-Forsch. 16, 1038–1050 (1966)
Hoffer, B.J., Siggins, G.R., Bloom, F.E.: Studies on norepinephrine-containing afferents to Purkinje cells of rat cerebellum. II. Sensitivity of Purkinje cells to norepinephrine and related substances administered by microiontophoresis. Brain Res. 25, 523–534 (1971)
Iversen, L.L., Rogawski, M.A., Miller, R.J.: Comparison of the effects of neuroleptic drugs on pre- and postsynaptic dopaminergic mechanisms in the rat striatum. Mol. Pharmacol. 12, 251–262 (1976)
Jackson, D.M., Andén, N.-E., Dahlström, A.: A functional effect of dopamine in the nucleus accumbens and in some other dopamine-rich parts of the rat brain. Psychopharmacologia 45, 139–149 (1975)
Janssen, P.A.J., Niemegeers, C.J.E., Schellekens, K.H.L.: Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? Part I. “Neuroleptic activity spectra” for rats. Arzneim.-Forsch. 15, 104–117 (1965)
Javoy, F., Agid, Y., Bouvet, D., Glowinski, J.: In vivo estimation of tyrosine hydroxylation in the dopaminergic terminals of the rat neostriatum. J. Pharm. Pharmacol. 26, 179–185 (1974)
Kehr, W.: Temporal changes in catecholamine synthesis of rat forebrain structures after axotomy. J. Neural Transm. 35, 307–317 (1974)
Kehr, W.: 3-Methoxytyramine as an indicator of impulse-induced dopamine release in rat brain in vivo. Naunyn-Schmiedebergs Arch. Pharmacol. 293, 209–215 (1976)
Kehr, W., Carlsson, A., Lindqvist, M., Magnusson, T., Atack, C.: Evidence for a receptor-mediated feedback control of striatal tyrosine hydroxylase activity. J. Pharm. Pharmacol. 24, 744–147 (1972)
Kehr, W., Carlsson, A., Lindqvist, M.: Catecholamine synthesis in rat brain after axotomy: interaction between apomorphine and haloperidol. Naunyn-Schmiedebergs Arch. Pharmacol. 297, 111–117 (1977)
Keller, H.H., Bartholini, G., Pletscher, A.: Increase of 3-methoxy-4-hydroxyphenylethylene glycol in rat brain by neuroleptic drugs. Eur. J. Pharmacol. 23, 183–186 (1973)
Kemp, J.M., Powell, T.P.S.: The synaptic organization of the caudate nucleus. Philos. Trans. R. Soc. Lond. [Biol.] 262, 403–412 (1971)
Kirpekar, S.M., Puig, M.: Effect of flow-stop on noradrenaline release from normal spleens and spleens treated with cocaine, phentolamine or phenoxybenzamine. Br. J. Pharmacol. 43, 359–369 (1971)
Korf, J., Roth, R.H., Aghajanian, G.K.: Alterations in turnover and endogenous levels of norepinephrine in cerebral cortex following electrical stimulation and acute axotomy of cerebral noradrenergic pathways. Eur. J. Pharmacol. 23, 276–282 (1973 a)
Korf, J., Aghajanian, G.K., Roth, R.H.: Stimulation and destruction of the locus coeruleus: opposite effects on 3-methoxy-4-hydroxyphenylglycol sulfate levels in the rat cerebral cortex. Eur. J. Pharmacol. 21, 305–310 (1973 b)
Korf, J., Grasdijk, L., Westerink, B.H.C.: Effects of electrical stimulation of the nigrostriatal pathway of the rat on dopamine metabolism. J. Neurochem. 26, 579–584 (1976 a)
Korf, J., Zieleman, M., Westerink, B.H.C.: Dopamine release in substantia nigra? Nature 260, 257–258 (1976b)
Kostowski, W., Giacalone, E., Garattini, S., Valzelli, L.: Electrical stimulation of midbrain raphe: biochemical, behavioral and bioelectrical effects. Eur. J. Pharmacol. 7, 170–175 (1969)
Lal, S., Sourkes, T.L., Missala, K., Belendiuk, G.: Effects of aporphine and emetine alkaloids on central dopaminergic mechanisms in rats. Eur. J. Pharmacol. 20, 71–79 (1972)
Langer, S.Z.: Presynaptic regulation of catecholamine release. Biochem. Pharmacol. 23, 1793–1800 (1974)
Laverty, R., Sharman, D.F.: Modification by drugs of the metabolism of 3,4-dihydroxyphenylethylamine, noradrenaline and 5-hydroxytryptamine in the brain. Br. J. Pharmacol. 24, 759–772 (1965)
Libet, B.: Generation of slow inhibitory and excitatory postsynaptic potentials. Fed. Proc. 29, 1945–1956 (1970)
Lin, R.C., Ngai, S.H., Costa, E.: Lysergic acid diethylamide: role in conversion of plasma tryptophan to brain serotonin (5-hydroxytryptamine). Science 166, 237–239 (1969)
Lundberg, A.: Adrenaline and transmission in the sympathetic ganglion of the cat. Acta Physiol. Scand. 26, 252–263 (1952)
Magnusson, T.: Effect of chronic transection on dopamine, noradrenaline and 5-hydroxytryp- tamine in the rat spinal cord. Naunyn-Schmiedebergs Arch. Pharmacol. 278, 13–22 (1973)
Magnusson, T., Rosengren, E.: Catecholamines of the spinal cord normally and after transection. Experientia 19, 229 (1963)
Maj, J., Sowinska, H., Baran, L., Kapturkiewicz, Z.: The effect of clonidine on locomotor activity in mice. Life Sci. 11 (I), 483–491 (1972)
Marrazzi, A.S.: Electrical studies on the pharmacology of autonomic synapses. II. The action of a sympathomimetic drug (epinephrine) on sympathetic ganglia. J. Pharmacol. Exp. Ther. 65, 395–404 (1939)
Meek, J.L., Neff, N.H.: The rate of formation of 3-methoxy-4-hydroxyphenyl-ethyleneglycol sulfate in brain as an estimate of the rate of formation of norepinephrine. J. Pharmacol. Exp. Ther. 184, 570–575 (1973)
Munkvad, I., Randrup, A.: The persistance of amphetamine stereotypies of rats in spite of strong sedation. Acta Psychiatr. Scand. 42 [Suppl. 191], 178–187 (1966)
Murrin, L.C., Roth, R.H.: Dopaminergic neurons: effects of electrical stimulation on dopamine biosynthesis. Mol. Pharmacol. 12, 463–475 (1976)
Nybäck, H.: Effect of brain lesions and chlorpromazine on accumulation and disappearance of catecholamines formed in vivo from 14C-tyrosine. Acta Physiol. Scand. 84, 54–64 (1972)
Nybäck, H., Sedvall, G.: Effect of chlorpromazine on accumulation and disappearance of catecholamines formed from tyrosine-C14 in brain. J. Pharmacol. Exp. Ther. 162, 294–301 (1968)
Nybäck, H., Sedvall, G.: Further studies on the accumulation and disappearance of catecholamines formed from tyrosine-14C in mouse brain. Effect of some phenothiazine analogues. Eur. J. Pharmacol. 10, 193–205 (1970)
Nybäck, H., Schubert, J., Sedvall, G.: Effect of apomorphine and pimozide on synthesis and turnover of labelled catecholamines in mouse brain. J. Pharm. Pharmacol. 22, 622–624 (1970)
O’Keeffe, R., Sharman, D.F., Vogt, M.: Effect of drugs used in psychoses on cerebral dopamine metabolism. Br. J. Pharmacol. 38, 287–304 (1970)
Persson, T.: Drug induced changes in 3H-catecholamine accumulation after 3H-tyrosine. Acta Pharmacol. (Kbh.) 28, 378–390 (1970)
Persson, T., Waldeck, B.: Further studies on the possible interaction between dopamine and noradrenaline containing neurons in the brain. Eur. J. Pharmacol. 11, 315–320 (1970)
Philippu, A., Roensberg, W., Przuntek, H.: Effects of adrenergic drugs on pressor responses to hypothalamic stimulation. Naunyn-Schmiedebergs Arch. Pharmacol. 278, 373–386 (1973)
Pieri, L., Pieri, M., Haefely, W.: LSD as an agonist of dopamine receptors in the striatum. Nature 252, 586–588 (1974)
Pijnenburg, A.J.J., Rossum, J.M. van: Stimulation of locomotor activity following injection of dopamine into the nucleus accumbens. J. Pharm. Pharmacol. 25, 1003–1005 (1973)
Portig, P.J., Vogt, M.: Release into the cerebral ventricles of substances with possible transmitter function in the caudate nucleus. J. Physiol. (Lond.) 204, 687–715 (1969)
Randic, M., Padjen, A.: Effect of N,N-dimethyltryptamine and d-lysergic acid diethylamide on the release of 5-hydroxyindoles in rat forebrain. Nature 230, 532–533 (1971)
Randrup, A., Munkvad, I.: DOPA and other naturally occurring substances as causes of stereotypy and rage in rats. Acta Psychiatr. Scand. 42 [Suppl. 191], 193–199 (1966 a)
Randrup, A., Munkvad, I.: Role of catecholamines in the amphetamine excitatory response. Nature 211, 540 (1966 b)
Randrup, A., Munkvad, I.: Behavioural stereotypies induced by pharmacological agents. Pharmakopsychiatr. Neuropsychopharmakol. 1, 18–26 (1968)
Rochette, L., Bralet, A.-M., Bralet, J.: Influence de la clonidine sur la synthèse et la libération de la noradrenaline dans différentes structures cérébrales du rat. J. Pharmacol. (Paris) 5, 209–220 (1974)
Roos, B.-E.: Decrease in homo vanillic acid as evidence for dopamine receptor stimulation by apomorphine in the neostriatum of the rat. J. Pharm. Pharmacol. 21, 263–264 (1969)
Rosecrans, J.A., Lovell, R.A., Freedman, D.X.: Effects of lysergic acid diethylamide on the metabolism of brain 5-hydroxytryptamine. Biochem. Pharmacol. 16, 2011–2021 (1967)
Roth, R.H., Stjarne, L., Euler, U.S. von: Factors influencing the rate of norepinephrine biosynthesis in nerve tissue. J. Pharmacol. Exp. Ther. 158, 373–377 (1967)
Roth, R.H., Walters, J.R., Aghajanian, G.K.: Effect of impulse flow on the release and synthesis of dopamine in the rat striatum. In: Frontiers in catecholamine research. Usdin, E., Snyder, S.H. (eds.), pp. 567–574. New York: Pergamon 1973
Roth, R.H., Murrin, L.C., Walters, J.R.: Central dopaminergic neurons: effects of alterations in impulse flow on the accumulation of dihydroxyphenylacetic acid. Eur. J. Pharmacol. 36, 163–171 (1976)
Scheel-Kriiger, J.: Studies on the accumulation of O-methylated dopamine and noradrenaline in the rat brain following various neuroleptics, thymoleptics and aceperone. Arch. Int. Pharmacodyn. 195, 372–378 (1972)
Schubert, J.: Effect of spinal transection on the metabolism of 5-hydroxyindoles formed in vivo from 3H-tryptophan in the rat spinal cord. Acta Physiol. Scand. 87, 557–566 (1972)
Schubert, J., Nybäck, H., Sedvall, G.: Accumulation and disappearance of 3H-5-hydroxytryptamine formed from 3H-tryptophan in mouse brain; effect of LSD-25. Eur. J. Pharmacol. 10, 215–224 (1970)
Sedvall, G.C., Kopin, I.J.: Acceleration of norepinephrine synthesis in the rat submaxillary gland in vivo during sympathetic nerve stimulation. Life Sci. 6, 45–51 (1967)
Segal, M., Bloom, F.E.: The action of norepinephrine in the rat hippocampus. I. Iontophoretic studies. Brain Res. 72, 79–97 (1974 a)
Segal, M., Bloom, F.E.: The action of norepinephrine in the rat hippocampus. II. Activation of the input pathway. Brain Res. 72, 99–114 (1974 b)
Sheard, M.H., Aghajanian, G.K.: Stimulation of the midbrain raphe: effect on serotonin metabolism. J. Pharmacol. Exp. Ther. 163, 425–430 (1968)
Shields, P.J., Eccleston, D.: Effects of electrical stimulation of rat midbrain on 5-hydroxytryptamine synthesis as determined by a sensitive radioisotope method. J. Neurochem. 19, 265–272 (1972)
Shields, P.J., Eccleston, D.: Evidence for the synthesis and storage of 5-hydroxytryptamine in two separate pools in the brain. J. Neurochem. 20, 881–888 (1973)
Spector, S., Sjoerdsma, A., Udenfriend, S.: Blockade of endogenous norepinephrine synthesis by α-methyl-tyrosine, an inhibitor of tyrosine hydroxylase. J. Pharmacol. Exp. Ther. 147, 86–95 (1965)
Starke, K.: Influence of α-receptor stimulants on noradrenaline release. Naturwissenschaften 58, 420 (1971)
Starke, K.: Regulation of noradrenaline release by presynaptic receptor systems. Rev. Physiol. Biochem. Pharmacol. 77, 1–124 (1977)
Starke, K., Altmann, K.P.: Inhibition of adrenergic neurotransmission by clonidine: an action on prejunctional α-receptors. Neuropharmacol. 12, 339–347 (1973)
Starke, K., Montel, H.: Alpha-receptor-mediated modulation of transmitter release from central noradrenergic neurones. Naunyn-Schmiedebergs Arch. Pharmacol. 279, 53–60 (1973 a)
Starke, K., Montel, H.: Involvement of α-receptors in clonidine-induced inhibition of transmitter release from central monoamine neurones. Neuropharmacol. 12, 1073–1080 (1973 b)
Starke, K., Montel, H.: Sympathomimetic inhibition of noradrenaline release: mediated by prostaglandins? Naunyn-Schmiedebergs Arch. Pharmacol. 278, 111–116 (1973c)
Starke, K., Montel, H.: Interaction between indomethacin, oxymetazoline and phentolamine on the release of [3H] noradrenaline from brain slices. J. Pharm. Pharmacol. 25, 758–759 (1973 d)
Starke, K., Borowski, E., Endo, T.: Preferential blockade of presynaptic a-adrenoceptors by yohimbine. Eur. J. Pharmacol. 34, 385–388 (1975 a)
Starke, K., Endo, T., Taube, H.D.: Relative pre- and postsynaptic potencies of α-adrenoceptor agonists in the rabbit pulmonary artery. Naunyn-Schmiedebergs Arch. Pharmacol. 291, 55–78 (1975 b)
Starke, K., Endo, T., Taube, H.D., Borowski, E.: Presynaptic receptor systems on noradrenergic nerves. In: Chemical tools in catecholamine research, Vol. II. Almgren, O., Carlsson, A., Engel, J. (eds.), pp. 193–200. Amsterdam, Oxford: North-Holland 1975 c
Stjärne, L.: Prostaglandin- versus α-adrenoceptor-mediated control of sympathetic neurotransmitter secretion in guinea-pig isolated vas deferens. Eur. J. Pharmacol. 22, 233–238 (1973)
Stock, G., Magnusson, T., Andén, N.-E.: Increase in brain dopamine after axotomy or treatment with gammahydroxybutyric acid due to elimination of the nerve impulse flow. Naunyn-Schmiedebergs Arch. Pharmacol. 278, 347–361 (1973)
Strömbom, U.: Catecholamine receptor agonists. Effects on motor activity and rate of tyrosine hydroxylation in mouse brain. Naunyn-Schmiedebergs Arch. Pharmacol. 292, 167–176 (1976)
Strömbom, IL: Antagonism by haloperidol of locomotor depression induced by small doses of apomorphine. J. Neural Transm. 40, 191–194 (1977)
Svensson, T.H.: Central α-adrenoceptors and affective symptoms and disorders. In: Depressive disorders. Symposia Medica Hoechst 13. Lindenlaub, E., Garattini, S. (eds.), pp. 245–254. Stuttgart, New York: Schattauer 1978
Svensson, T.H., Bunney, B.S., Aghajanian, G.K.: Inhibition of both noradrenergic and serotonergic neurons in brains by the a-adrenergic agonist Clonidine. Brain Res. 92, 291–306 (1975)
Thoenen, H.: Trans-synaptic enzyme induction. Life Sci. 14, 223–235 (1974)
Thoenen, H., Hiirlimann, A., Haefely, W.: Wirkungen von Phenoxybenzamin, Phentolamin und Azapetin auf adrenergische Synapsen der Katzenmilz: Blockierung der α-adrenergi- schen Rezeptoren und Hemmung der Wiederaufnahme von neural freigesetztem Noradrenalin. Helv. Physiol. Pharmacol. Acta 22, 148–161 (1964)
Trendelenburg, U.: Some aspects of the pharmacology of autonomic ganglion cells. Ergebn. Physiol 59, 1–85 (1967)
Trulson, M.E., Jacobs, B.L.: Raphe neurons: depression of activity by L-5-hydroxytryptophan. Brain Res. 97, 350–355 (1975)
Ungerstedt, U., Butcher, L.L., Butcher, S.G., Andén, N.-E., Fuxe, K.: Direct chemical stimulation of dopaminergic mechanisms in the neostriatum of the rat. Brain Res. 14, 461–471 (1969)
Walter, D.S., Eccleston, D.: Increase of noradrenaline metabolism following electrical stimulation of the locus coeruleus in the rat. J. Neurochem. 21, 281–289 (1973)
Walters, J.R., Roth, R.H.: Dopaminergic neurons: drug-induced antagonism of the increase in tyrosine hydroxylase activity produced by cessation of impulse flow. J. Pharmacol. Exp. Ther. 191, 82–91 (1974)
Walters, J.R., Roth, R.H.: Dopaminergic neurons - alteration in the sensitivity of tyrosine hydroxylase to inhibition by endogenous dopamine after cessation of impulse flow. Biochem. Pharmacol. 25, 649–654 (1976 a)
Walters, J.R., Roth, R.H.: Dopaminergic neurons: an in vivo system for measuring drug interactions with presynaptic receptors. Naunyn-Schmiedebergs Arch. Pharmacol. 296, 5–14 (1976 b)
Walters, J.R., Roth, R.H., Aghajanian, G.K.: Dopaminergic neurons: similar biochemical and histochemical effects of γ-hydroxybutyrate and acute lesions of the nigro-neostriatal pathway. J. Pharmacol. Exp. Ther. 186, 630–639 (1973)
Weiner, N., Lee, F.-L.: The role of calcium in norepinephrine release and synthesis. In: Chemical tools in catecholamine research, Vol. II. Almgren, O., Carlsson, A., Engel, J. (eds.), pp. 61–71. Amsterdam, Oxford: North-Holland 1975
Weissman, A., Koe, B.K., Tenen, S.S.: Antiamphetamine effects following inhibition of tyrosine hydroxylase. J. Pharmacol. Exp. Ther. 151, 339–352 (1966)
Werner, IL, Starke, K., Schümann, H.J.: Actions of Clonidine and 2-(2-methyl-6-ethyl-cyclo- hexylamino)-2-oxazoline on postganglionic autonomic nerves. Arch. Int. Pharmacodyn. 195, 282–290 (1972)
Westerink, B.H.C., Korf, J.: Regional rat brain levels of 3,4-dihydroxyphenylacetic acid and homovanillic acid: concurrent fluorometric measurement and influence of drugs. Eur. J. Pharmacol. 38, 281–291 (1976)
Wiesel, F.-A., Sedvall, G.: Effect of antipsychotic drugs on homovanillic acid levels in striatum and olfactory tubercle of the rat. Eur. J. Pharmacol. 30, 364–367 (1975)
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1980 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Andén, NE. (1980). Regulation of Monoamine Synthesis and Utilization by Receptors. In: Szekeres, L. (eds) Adrenergic Activators and Inhibitors. Handbook of Experimental Pharmacology, vol 54 / 1. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-67505-8_10
Download citation
DOI: https://doi.org/10.1007/978-3-642-67505-8_10
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-67507-2
Online ISBN: 978-3-642-67505-8
eBook Packages: Springer Book Archive